The pan-cancer analysis showed that the expression level of BATF2 mRNA in breast invasive carcinoma (BRCA) was slightly lower than that in normal controls, but without a significant difference (Fig. 2A and B). The gene discussed is BATF2; the disease is invasive breast carcinoma.